Advancing MASLD Care: A DCES Guide to Managing MASLD in People with Diabetes

60-minute Program
Effective dates for CE credit: 6/3/2026 – 6/3/2028

Description

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide, affecting up to 70% of people with diabetes or obesity, yet remains frequently unrecognized. With rapid treatment advances, including two FDA-approved therapies for metabolic dysfunction-associated steatohepatitis (MASH), DCES can play a vital role in identifying and managing this cardiometabolic comorbidity. This session provides practical screening strategies, including FIB-4 calculation, evidence-based pharmacologic interventions following current guidelines, and comprehensive diabetes management approaches for people with MASLD. Through case-based application, attendees will gain actionable tools to identify, risk-stratify, and manage MASLD in clinical practice.

Learning Outcome

By the conclusion of this activity, participants will report increased confidence in their ability to identify, risk-stratify, and support the management of MASLD in people with diabetes, including applying screening strategies (e.g., FIB-4) and incorporating evidence-based treatment approaches into care.

Learning Objectives

At the end of this presentation, participants will be able to:
• Identify people with diabetes at high risk for metabolic dysfunction-associated steatotic liver disease (MASLD) with clinically significant fibrosis. 
• Interpret current guideline recommendations for reducing risk of cardiovascular disease and hepatic complications in people with diabetes and MASLD. 
• Develop comprehensive evidence-based treatment and education plans to improve hepatic and cardiometabolic outcomes in people with diabetes.

Activity Type

This recording of a live presentation is a knowledge-based learning activity.

Learning Format

Enduring Material

Intended Audience

This activity is designed for diabetes care and education specialists, including nurses, dietitians, pharmacists, physicians, PAs, and other health care providers interested in staying up to date on current practices of care for people with diabetes and other related conditions.

Financial Support

None

Access Period

You will have access to this learning activity for a period of six months after you enroll, or whenever the activity's CE credits expire (whichever comes first).

Originally presented on: 6/3/2026
Expiration date: 6/3/2028

Sarah Wheeler, PharmD, BCACP, CDCES 
Assistant Professor 
Department of Pharmacotherapy and Outcomes Science 
VCU School of Pharmacy

John Bucheit, PharmD, BCACP, CDCES, FCCP, FADCES, AACC 
Associate Professor and PGY2 Ambulatory Care Residency Director 
Department of Pharmacotherapy and Outcomes Science 
VCU School of Pharmacy

Faculty Disclosures

In accordance with Joint Accreditation criteria and the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, the Association of Diabetes Care & Education Specialists (ADCES) must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any ineligible companies for the past 24 months.

Joint Accreditation/ACCME requires ADCES to identify and mitigate all relevant financial relationships with ineligible companies to ensure educational content is balanced, evidence-based, and free from bias. Disclosure information is provided to help learners recognize any relevant financial relationships and make their own informed judgments about the content. If you perceive any bias during the activity, please report it through the evaluation form.

Relevant disclosures (or lack thereof) among educational activity planners and faculty are as follows:

Speakers/Planners

Sarah Wheeler, PharmD, BCACP, CDCES - No relevant financial relationships 
John Bucheit, PharmD, BCACP, CDCES, FCCP, FADCES, AACC - Amgen and Esperion: Research funded through American College of Cardiology

Peer Reviewers

Tania C Bezerra, MA, RDN, LDN, CDCES - No relevant financial relationships
Helen Pervanas, PharmD - No relevant financial relationships
Christine Zaveson, RN, MSN, PHN, CDCES - No relevant financial relationships
Bau Tran, PA-C, PharmD - No relevant financial relationships
Cassandra Henderson, MD, MSc, CDCES - No relevant financial relationships

All relevant financial relationships have been mitigated.

The approval of this educational offering by the ADCES does not imply endorsement of specific therapies, treatments, or products discussed in the presentations.

In support of improving patient care, the Association of Diabetes Care & Education Specialists is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

	Accreditation Council for Pharmacy Education (ACPE) The Universal Activity Number is JA4008258-0000-26-259-H01-P. This knowledge-based activity has been approved for 1.0 contact hour(s). This statement contains information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor.
	American Medical Association (AMA) Association of Diabetes Care & Education Specialists designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
	American Nurses Credentialing Center (ANCC) Association of Diabetes Care & Education Specialists designates this activity for a maximum of 1.0 ANCC contact hour(s). This activity discusses 0.50 contact hour(s) of pharmacotherapeutic content.  The Association of Diabetes Care & Education Specialists is approved by the California Board of Registered Nursing, Provider Number 10977, for 1.0 contact hour(s).
	American Academy of PAs (AAPA) The Association of Diabetes Care & Education Specialists has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit(s). Approval is valid until 6/3/28. PAs should only claim credit commensurate with the extent of their participation.

Commission on Dietetic Registration (CDR) CDR Credentialed Practitioners will receive 1.0 Continuing Professional Education unit(s) (CPEU) for completion of this activity.  Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit = One CPEU). If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One 60 minute hour = 1 CPEU. RDs and DTRs are to select activity type 102 in their Activity Log. Performance Indicator selection is at the learner’s discretion.

Association of Social Work Boards (ASWB)  As a Jointly Accredited Organization, the Association of Diabetes Care & Education Specialists is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.0 general continuing education credit(s).

Successful Completion

To receive a Statement of Credit, you must participate in all identified components of the activity and complete an evaluation.

Certified Diabetes Care and Education Specialists

To satisfy the requirements for renewal of certification for the Certification Board for Diabetes Care and Education (CBDCE), continuing education activities must be diabetes related and approved by a provider on the CBDCE list of Approved Providers (www.cbdce.org). CBDCE does not approve continuing education. The Association of Diabetes Care & Education Specialists is on the CBDCE list of Approved Providers.

Board Certified Advanced Diabetes Management (BC-ADM)

CBDCE is the administering body for the Advanced Diabetes Management credentials. Continuing education programs offered by ADCES can be used toward fulfilling BC-ADM Certification and recertification requirements.

Other Health Professionals

It is the responsibility of each participant to determine if the program meets the criteria for re-licensure or recertification for their discipline.

Members: $29.95
Non-Members: $44.95

Volume discounts are available and will be automatically applied at check-out when the desired quantity is selected
-- Groups of 4-9: 10% off
-- Groups of 10-19: 20% off
-- Groups of 20-29: 30% off
-- Groups of 30+: 40% off

ADCES CBs and LNGs: Please contact us at [email protected] to order a recorded webinar for a group viewing.

Not an ADCES member? Join today to get discounted member pricing on all events and products!